Last checked at 14 Mar 2023 07:00
Craneware plc
("Craneware", "The Craneware Group", the "Company" or the "Group")
Director Share Purchase
14 March 2023 - Craneware (AIM: CRW.L), the market leader in Value Cycle solutions for the US healthcare market, has been notified that on 13 March, Keith Neilson, CEO of the Company, purchased 3,484 ordinary shares of 1p each in the Company ("Ordinary Shares") at a price of 1435p per Ordinary share.
Following the purchase, Mr. Neilson holds 3,446,539 Ordinary Shares in the capital of the Company, representing 9.7% of the Company's issued share capital.
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them:
1. Details of the Restricted Person / person closely associated with him or her
| |
a) Name | Keith Neilson |
2. Reason for the notification
| |
a) Position / status | CEO |
b) Initial notification / Amendment | Initial notification |
| |
3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
| |
a) Name | Craneware plc |
b) LEI | 213800O2CTJ1YFXNXG05 |
| |
4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
| |
a) Description of the financial instrument, type of instrument | Ordinary Shares of 1p each in the capital of Craneware plc |
b) Identification code | ISIN GB00B2425G68 |
c) Nature of the transaction | Purchase of Ordinary Shares |
d) Price(s) and volume(s) | Volume(s) 3484 Price(s) £14.35 |
e) Aggregated information: i. Aggregated volume ii. Price | N/A (single transaction) - - |
f) Date of the transaction | 2023-03-13 |
g) Place of the transaction | London Stock Exchange (XLON) |
For further information, please contact:
Craneware plc | +44 (0)131 550 3100 |
Keith Neilson, CEO | |
Craig Preston, CFO | |
Alma (Financial PR) | +44 (0)20 3405 0205 |
Caroline Forde, Joe Pederzolli, Kinvara Verdon | craneware@almapr.co.uk |
Peel Hunt (NOMAD and Joint Broker) | +44 (0)20 7418 8900 |
Dan Webster, Andrew Clark | |
Investec Bank PLC (Joint Broker) | +44 (0)20 7597 5970 |
Patrick Robb, Henry Reast, Sebastian Lawrence | |
Berenberg (Joint Broker) | +44 (0)20 3207 7800 |
Mark Whitmore, Richard Andrews, Dan Gee-Summons |
About Craneware
We at The Craneware Group of companies, including our latest additions Sentry Data Systems and Agilum Healthcare Intelligence, passionately believe we can impact healthcare profoundly by delivering the insights healthcare organisations need to also transform the business of healthcare. Our shared vision is to be the operational and financial partner for US healthcare providers.
Our combined suite of applications and industry-leading team of experts help our customers contextualise operational, financial, and clinical data, providing insights that clearly demonstrate what great looks like. These value cycle insights deliver revenue integrity and 340B compliance, as well as margin and operational intelligence - something no other single partner can provide.
Together, approximately 40% of registered US hospitals are now our customers, including more than 12,000 US hospitals, health systems and affiliated retail pharmacies and clinics. Our customers are operating with a financial impact of nearly half a trillion dollars. We have data sets from customers covering more than 150 million unique patients encounters.
Learn more at www.thecranewaregroup.com